Swapnil Rajurkar, M.D.
- Hematology-Oncology
- Breast Cancer
- Gynecological Oncology
- Thoracic Oncology
- Urologic Oncology
- Assistant Clinical Professor, Department of Medical Oncology & Therapeutics Research
An active member in the American Society of Clinical Oncology and the American Society of Hematology, Swapnil Rajurkar, M.D., has published in the Journal of Clinical Oncology and presented at several major clinical conferences.
As an oncologist, Dr. Rajurkar is especially interested in lung, prostate and gynecological cancers. His personal hobbies and interests include spending time with his family and tennis, which he finds is a great form of exercise and relaxation. He states, “My goal is to provide compassionate and individualized treatment for my patients through the use of evidence-based medicine, access to the best technology and enrollment in clinical trials.”
Location
Upland
Suite 1100
Upland, CA 91786
Education & Experience
2007, American Board of Internal Medicine - Subspecialty of Medical Oncology
2005, American Board of Internal Medicine
1995 - 1999, M.B.B.S., Government Medical College, Surat, India
2005–2007, Medical Oncology, University of Colorado Health Sciences Center, Aurora, Colorado
2002–2005, Internal Medicine, McLaren Regional Medical Center, Flint, Michigan
2000–2001, Medical Internship, New Civil Hospital, Surat, India
2014-Present, Assistant Clinical Professor, City of Hope, Upland, CA
2008–2013, Staff Physician, Hematology, Medical Oncology, Wilshire Oncology Medical Group, Inc., Rancho Cucamonga, CA
2007–2008, Private Practice, Hematology, Medical Oncology, Private Medical Oncology, Hematology Practice, Upland and Chino, CA
Awards & Memberships
Awards
2009, ASCO Clinical Trials Participation Award
Memberships
2011, Medical Oncology Association of Southern California
2005, American Society of Oncology
Publications
- Swapnil P. Rajurkar MD, Cary A. Presant, MD, FACP, Linda D. Bosserman, MD, FACP, and Wendy J. McNatt. Wilshire Oncology Medical Group, LaVerne, CA. “A Copay Foundation Assistance Support Program for Patients Receiving Intravenous Cancer Therapy.” Journal of Oncology Practice, Vol 7, Issue 2, 2011:100-102.
- Swapnil P. Rajurkar MD, Gordon Tam, Janice Lau “Waldenstrom’s Macroglobulinemia- A Case Report” Southern California Clinicians, Vol 9, Issue 1, 2015: 43-46
- Swapnil P. Rajurkar MD, Christopher Felten MD, Joel Chan MD, Jean Lopategui MD, Dulce Decastro MD, Blastoid Variant Mantle Cell Lymphoma Expressing Aberrant CD3 and CD10 with Concurrent Small Lymphocytic Lymphoma: Establishment of a Clonal Relationship by B- and T-Cell Receptor Gene Rearrangements," Case Reports in Hematology, vol. 2018, Article ID 8303571, 10 pages, 2018.
- Marilena Melas, Shanmuga Subbiah, Siamak Saadat, Swapnil Rajurkar and Kevin J. McDonnell. The Community Oncology and Academic Medical Center Alliance in the Age of Precision Medicine: Cancer Genetics and Genomics Considerations. J. Clin. Med. 2020, 9, 2125; doi:10.3390/jcm9072125
- Jeremy Fricke, Isa Mambetsariev, Rebecca Pharaon, Shanmuga Subbiah, Swapnil Rajurkar, Ravi Salgia. Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report. 2020 Nov 13;99(46):e22323.
- Xuan G, Yost S, Lee J, Rajurkar S, Mortimer J, Yuan Y. Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer Cancers 2022, 14(17), 4279
- P Kulkarni, A Mohanty, S Bhattacharya, S Singhal, L Guo, S Ramisetty, T Mirzapoiazova, B Mambetsariev, J Malhotra, N Gupta, P Kim, R Babikian, S Rajurkar, S Subbiah, T Tan, D Nguyen, A Merla, S Kollimuttathuillam, T Phillips, B Peter, B Leach, R Garg, F Stewart MD, R Salgia. Addressing Drug Resistance in Cancer: A Team Medicine Approach J. Clin. Med. 2022, 11(19), 5701
- Bosserman L, Mambetsariev I, Ladbury C, Barzi A, Johnson D, Morse D, Deaville D, Smith W, Rajurkar S, Merla A, Hajjar G, Kim D, Fricke J, Trisal V, Salgia R.Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans J. Clin. Med. 2022, 11(22), 6738
- Ramisetty S, Kulkarni P, Bhattacharya, Nam A, Singhal S, Guo L, Mirzapoiazova T, Mambetsariev B, Mittan S, Malhotra J, Pisick E, Subbiah S, Rajurkar, S, Massarelli E, Salgia R, Mohanty A. A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer J. Clin. Med. 2023, 12(2), 599
- Rajurkar S, Mambetsariev I, Pharaon R, Leach B, Tan T, Kulkarni P, Salgia R. Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy strategies. J. Clin. Med. 2020, 9(6),1870; https://doi.org/10.3390/jcm9061870